Guided Therapeutics (GTHP) Raw Materials (2014 - 2021)

Guided Therapeutics (GTHP) has 8 years of Raw Materials data on file, last reported at $1.3 million in Q1 2021.

• For the quarter ending Q1 2021, Raw Materials rose 63.09% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2021 stood at $1.3 million (up 63.09% YoY), and the FY2020 full-year result was $1.3 million, up 63.38% from the prior year.
• Raw Materials steadied at $1.3 million in Q1 2021, from $1.3 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $1.3 million in Q1 2021 to a low of $781000.0 in Q1 2019.
• A 5-year average of $844294.1 and a median of $789000.0 in 2017 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials retreated 7.77% in 2017 and soared 63.38% in 2020, its largest moves.
• Tracing GTHP's Raw Materials over 5 years: stood at $789000.0 in 2017, then fell by 0.76% to $783000.0 in 2018, then decreased by 0.26% to $781000.0 in 2019, then soared by 63.38% to $1.3 million in 2020, then advanced by 0.08% to $1.3 million in 2021.
• Business Quant data shows GTHP's Raw Materials at $1.3 million in Q1 2021, $1.3 million in Q4 2020, and $782000.0 in Q3 2020.